A tablet including high dosage of 8 fluoro 2 (4 [(methylamino)methyl]phenyl) 1 3 4 5 tetrahydro 6H azepino[5 4 3 cd]indol 6 one camsylate salt has been disclosed. The invention is directed to high dosage strength tablets of rucaparib. In some embodiments the tablet includes 45 90% w/w njcaparib camsylate. In some embodiments the dry granulated tablet includes 45 90% w/w rucaparib camsylate. One such embodiment is a tablet containing at least 200 mg rucaparib. Another embodiment is a tablet containing at least 300 mg rucaparib.
